$OFIX News

Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

Orthofix Medical (NASDAQ:OFIX) Jumps on Q2 Earnings Beat and Raised Guidance

Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript

Orthofix Medical Inc. 2026 Q2 - Results - Earnings Call Presentation

Orthofix Medical Raises FY2026 Sales Guidance from $838.000M-$848.000M to $845.000M-$855.000M vs $843.311M Est

Orthofix Medical Q2 Adj. EPS $0.07 Beats $(0.41) Estimate, Sales $210.933M Beat $209.277M Estimate

Reported July 2, 2026: Orthofix Medical Says Medicare Will Restore Pre-May 18 Reimbursement Rates For Bone Growth Stimulators After CMS Reversal

Orthofix Medical (OFIX) Stock Sees Split Analyst Revisions After CMS Reimbursement Reset

Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

How The Orthofix Medical (OFIX) Narrative Is Resetting After CMS Cuts And Guidance Changes

Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target

Orthofix Medical Inc. 2026 Q1 - Results - Earnings Call Presentation

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients

Orthofix Medical Q1 Earnings Call Highlights

Orthofix Medical Inc. Q1 2026 Earnings Call Summary